Clinical Trial Update: Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial compared aliskiren plus amlodipine versus amlodipine alone in African American patients with stage 2 hypertension to assess efficacy and safety;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• NORVASC (amlodipine besylate)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-01-21